Peer-influenced content. Sources you trust. No registration required. This is HCN.
The New England Journal of Medicine
With nearly ten years of follow-up, dabrafenib plus trametinib demonstrates a sustained improvement in survival outcomes for patients with stage III BRAF V600–mutated melanoma, presenting a viable long-term strategy in melanoma management.
Dermatology July 1st 2024
Oncology News Central (ONC)
A study on palliative care for advanced lung cancer patients shows that telehealth can match in-person visits in improving quality of life and patient satisfaction. These findings support the broader implementation of telehealth in oncology.
Oncology, Medical June 24th 2024
Cancer Therapy Advisor
AI chatbots like ChatGPT-4 and Claude AI have demonstrated superior performance to oncologists in delivering accurate, empathetic, and readable responses to patient inquiries about cancer, suggesting a promising adjunct to clinical practice.
Hematology/Oncology June 24th 2024
HIT Consultant
Tempus AI, leveraging one of the world’s largest clinical and molecular oncology data libraries, files for an IPO, aiming to raise substantial funds to support its mission of advancing AI-powered precision medicine.
The TROPiCs-04 trial results challenge the current treatment landscape for metastatic urothelial carcinoma, highlighting the need for new strategies post-relapse and the importance of next-generation sequencing in patient selection.
Oncology, Medical June 18th 2024
MD Newsline
IL-1B significantly influences breast cancer bone metastasis by promoting EMT, enhancing osteoclast activity, and creating a conducive metastatic niche. Targeting IL-1B in combination with standard therapies shows promising potential to reduce metastatic outgrowth.
Oncology, Medical June 17th 2024